F, B., L, J., A, A., M, V., G, B., O, M., . . . I, G. (2022). Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.
Citación estilo ChicagoF, Bermejo, et al. Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. 2022.
Cita MLAF, Bermejo, et al. Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. 2022.
Precaución: Estas citas no son 100% exactas.